Foresite Capital Management Iii, LLC Closed Holding Positions

Foresite Capital Management Iii, LLC

  • $37.9 Million
  • Q3 2022
Stock Closed Quarter Shares Sold Price Range Trade History
Acceleron Pharma Inc.
Q4 2021 Filed on Feb 11, 2022
108,630
N/A
ACRS
Aclaris Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 11, 2022
1,954,904
$12.27 - $18.49 $24M - $36.1M
EPZM
Epizyme, Inc.

Healthcare
Q4 2021 Filed on Feb 11, 2022
998,278
$2.5 - $5.19 $2.5M - $5.18M
NVAX
Novavax Inc

Healthcare
Q4 2021 Filed on Feb 11, 2022
5,000
$134.56 - $217.97 $673K - $1.09M
FGEN
Fibrogen Inc

Healthcare
Q3 2021 Filed on Nov 12, 2021
305,784
$10.18 - $26.64 $3.11M - $8.15M
Oric Pharmaceuticals, Inc.
Q1 2021 Filed on May 17, 2021
496,893
N/A
Myokardia, Inc.
Q4 2020 Filed on Feb 16, 2021
399,360
N/A
BPMC
Blueprint Medicines Corp

Healthcare
Q3 2020 Filed on Nov 13, 2020
249,598
$66.45 - $92.7 $16.6M - $23.1M
ORIC
Oric Pharmaceuticals, Inc.

Healthcare
Q3 2020 Filed on Nov 13, 2020
496,893
$19.5 - $31.26 $9.69M - $15.5M
Immunomedics, Inc.
Q2 2020 Filed on Aug 13, 2020
400,000
N/A
BHVN
Biohaven Pharmaceutical Holding CO Ltd.

Healthcare
Q2 2020 Filed on Aug 13, 2020
62,245
$29.01 - $74.23 $1.81M - $4.62M
AERI
Aerie Pharmaceuticals Inc

Healthcare
Q2 2020 Filed on Aug 13, 2020
356,492
$12.0 - $16.13 $4.28M - $5.75M
Audentes Therapeutics, Inc.
Q1 2020 Filed on May 14, 2020
233,067
N/A
REPL
Replimune Group, Inc.

Healthcare
Q1 2020 Filed on May 14, 2020
313,922
$8.9 - $19.08 $2.79M - $5.99M
Aimmune Therapeutics, Inc.
Q4 2019 Filed on Feb 14, 2020
611,893
N/A
Alder Bio Pharmaceuticals, Inc.
Q4 2019 Filed on Feb 14, 2020
2,393,612
N/A
Bio Delivery Sciences International, Inc.
Q3 2019 Filed on Nov 13, 2019
454,656
N/A
WVE
Wave Life Sciences Ltd.

Healthcare
Q3 2019 Filed on Nov 13, 2019
139,900
$19.17 - $27.4 $2.68M - $3.83M
Tocagen, Inc.
Q3 2019 Filed on Nov 13, 2019
568,054
N/A
Achaogen, Inc.
Q2 2019 Filed on Aug 13, 2019
2,864,664
N/A
SLDB
Solid Biosciences Inc.

Healthcare
Q1 2019 Filed on May 14, 2019
98,942
$7.19 - $32.37 $711K - $3.2M
SGMO
Sangamo Therapeutics, Inc

Healthcare
Q4 2018 Filed on Feb 13, 2019
265,605
$9.51 - $16.6 $2.53M - $4.41M
PACB
Pacific Biosciences Of California, Inc.

Healthcare
Q4 2018 Filed on Feb 13, 2019
1,135,000
$3.99 - $7.82 $4.53M - $8.88M
ARDX
Ardelyx, Inc.

Healthcare
Q4 2018 Filed on Feb 13, 2019
130,304
$1.66 - $4.16 $216K - $542K
Immunomedics, Inc.
Q3 2018 Filed on Nov 13, 2018
150,000
N/A
Immunomedics, Inc.
Q3 2018 Filed on Nov 13, 2018
150,000
N/A
Achaogen, Inc.
Q2 2018 Filed on Aug 14, 2018
200,000
N/A
Ra Pharmaceuticals, Inc.
Q2 2018 Filed on Aug 14, 2018
50,000
N/A
MDGL
Madrigal Pharmaceuticals, Inc.

Healthcare
Q4 2017 Filed on Feb 13, 2018
100,000
$39.35 - $97.37 $3.94M - $9.74M
ARGX
Argenx Se

Healthcare
Q4 2017 Filed on Feb 13, 2018
176,500
$22.57 - $63.56 $3.98M - $11.2M
Dermira, Inc.
Q4 2017 Filed on Feb 13, 2018
43,071
N/A
Loxo Oncology, Inc.
Q4 2017 Filed on Feb 13, 2018
50,000
N/A
INFI
Infinity Pharmaceuticals, Inc.

Healthcare
Q3 2017 Filed on Nov 13, 2017
738,896
$0.94 - $1.35 $695K - $998K
NSTG
Nano String Technologies Inc

Healthcare
Q3 2017 Filed on Nov 13, 2017
178,681
$13.68 - $16.57 $2.44M - $2.96M
Bellicum Pharmaceuticals, Inc.
Q3 2017 Filed on Nov 13, 2017
452,727
N/A
Orexigen Therapeutics, Inc.
Q3 2017 Filed on Nov 13, 2017
380,530
N/A
Zafgen, Inc.
Q3 2017 Filed on Nov 13, 2017
234,092
N/A
Abeona Therapeutics, Inc.
Q3 2017 Filed on Nov 13, 2017
18,334
N/A
Track This Portfolio

Track Foresite Capital Management Iii, LLC Portfolio

Follow Foresite Capital Management Iii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management Iii, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email